LectureRechercheRadarCadre d'investissement
Connexion / Inscription
← Retour à la lecture
ActualitésSujet · TesoraiPrise rapide1 min de lectureRédaction DisconfirmAI

AI Startup Tesorai Raises $5.3M Seed to Make Raw Lab Data Searchable

San Diego-based AI startup Tesorai secured $5.3M in seed funding, backed by Perplexity Fund and IQT, to build AI infrastructure that extracts insights from raw experimental data.

2026-11-18 22:00 GMT+8

San Diego-based AI startup Tesorai announced a $5.3 million seed round on November 18, bringing its total funding to $8 million. Investors include Perplexity Fund, IQT, South Central Ventures, New Stack Ventures, NextGen Venture Partners, f7 Ventures, VitalStage Ventures and ZAKA.

Tesorai aims to address a bottleneck in life sciences R&D: while millions of experiments generate vast amounts of raw data, much of it remains difficult to access, compare or reuse due to scattered formats and annotations. Unlike companies that index papers or aggregate existing analyses, Tesorai’s AI harmonises results across experiments directly from the underlying raw data, making them searchable.

The company claims its patented model has processed thousands of files and terabytes of data in hours, work that previously took months. In one example, Tesorai’s team reprocessed raw files from five public brain studies and recovered p-tau217, a leading Alzheimer’s marker that had never been reported in those specific studies.

Founded by former Verily leaders Melissa Miao, Peter Cimermancic and Charlie Kim, Tesorai plans to use the new funds to expand its platform beyond proteins to other molecular data and deepen partnerships with biopharmaceutical customers.

Sources

Connexion / Inscription
LectureRechercheRadarCadre d'investissement
techfundingnews.com
Tech Funding News
↗
Sujet

Tesorai

Tesorai, a San Diego-based AI startup founded by former Verily (Alphabet) leaders, announced a $5.3 million seed round o…

4 étapes1 piècesMis à jour 2026-11-21 20:40

Comment on en est arrivé là

  1. 2026-08-10August 10, 2026: JAMA Neurology publishes an Alzheimer's panel; Tesorai later recovers p-tau217 from raw data of five related studies.techfundingnews.com ↗
  2. 2026-08-31August 2026: Tesorai posts a preprint showing recovery of the Alzheimer's marker and another preprint demonstrating improved AI model performance with protein data.prnewswire.com ↗
  3. 2026-10-07October 7, 2026: A $1.8 billion effort involving Biohub, Google DeepMind, Meta, and Isomorphic Labs is announced to generate and standardize biological data for AI.prnewswire.com ↗

Ce qui reste non résolu

  • Will the recovered Alzheimer's biomarker findings pass peer review?
  • How will Tesorai's platform expansion into non-protein molecular data affect its competitive position against data-generation initiatives?
  • What specific metrics will demonstrate sustained adoption by biopharmaceutical customers?
Lire le sujet complet →
Continuer la recherche →